Tech Company Financing Transactions
AlloStem Therapeutics Funding Round
On 3/31/2011, AlloStem Therapeutics raised $75 thousand in financing from Connecticut Innovations.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$75,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
400 Farmington Ave.
Farmington, CT 06032
USA
Farmington, CT 06032
USA
Phone
Website
Email Address
Overview
AlloStem Therapeutics was formed to develop, and out-license, a novel class of MEK inhibitors represented by the lead compound CIP-1374.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Uday Khire
Browse more venture capital transactions:
Prev: 3/31/2011: Gen4 Energy venture capital transaction
Next: 3/31/2011: iMedX venture capital transaction
Share this article
Where The Data Comes From
We report on funding rounds that are announced publicly. All VC database entries on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs